Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put KaloBios' financial performance into perspective.

September 15,2014, Interview with David W. Pritchard, President and CEO

View all »   RSSRecent Releases

Aug 14, 2014
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy

Aug 7, 2014
KaloBios Provides Clinical Update and Reports Second Quarter Financial Results

Shareholder Tools

Search Investor Relations

You are now leaving this website. If you would like to continue, click Continue.